Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis

Corinne Goldsmith Dickinson Center for MS, New York

Maimonides MS Care Center, Brooklyn

SUNY Stony Brook, Stony Brook

University of Rochester, Rochester

Thomas Jefferson University Physicians, Philadelphia

Maryland Center for MS, Baltimore

CMC - Neuroscience & Spine Institute, Division of Neurology, Charlotte

Shepherd Center, Atlanta

Ohio State University MS Center, Columbus

Cleveland Clinic Foundation, Cleveland

The Schapiro Center for MS, Golden Valley

University of Chicago, Chicago

Washington University School of Medicine, Div. of Rehab/Neurology, St Louis

University of Texas-Houston, Houston

Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center, Phoenix

University of Mexico, MIND Imaging Center, Albuquerque

USC, Keck School of Medicine Health Care Consultation Center, Los Angeles

Oregon Health & Science University, MS Center of Oregon, UHS-42, Portland

MS Center at Evergreen, Kirkland

Gimbel MS Center at Holy Name Hospital, Teaneck

Foothills Medical Center, Calgary

St. Michael's Hospital, Toronto